Ennead Partner, Peter Schubert FAIA, authored an op-ed published in Commercial Observer about how "New Life Sciences Design Can Fill Empty New York Towers."
Demand for life sciences space in New York City grew 67 percent in 2021 alone, and the demand for life sciences space continues to surpass other sectors. Joining these government agencies and private-sector investors are leading institutions and nonprofits, merging the interests of the life sciences sector, academic institutions and the real estate community into a powerhouse partnership.
In a commercial environment that is still sluggish from the pandemic, New York’s major real estate dynasties see the opportunities in the life sciences because people want to do more than just work in New York. This is particularly important for biotech and life sciences companies, and their employees, who expect and seek high-performance environments with amenities and shared spaces. The dark lab isolated from the outside world with rows of lonely cubicles is a thing of the past. Researchers want the same quality of space as creatives. To remain competitive, real estate firms need to consider design quality along with user preference to attract life sciences clientele.
Read the full article here.